Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
2.300
+0.050 (2.22%)
At close: Jan 16, 2026, 4:00 PM EST
2.349
+0.049 (2.13%)
After-hours: Jan 16, 2026, 7:57 PM EST
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $2.7 million as of January 16, 2026. Its market cap has decreased by -1.84% in one year.
Market Cap
2.70M
Enterprise Value
-1.96M
1-Year Change
-1.84%
Ranking
Category
Stock Price
$2.30
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $2.70M, a decrease of -95.30%. That is a compound annual growth rate of -49.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 2.70M | -0.86% |
| Dec 31, 2025 | 2.73M | -0.99% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | 57.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |